CHICAGO (GenomeWeb News) – As researchers carve out a clearer view of clonal evolution in acute myeloid leukemia, new challenges are arising in trying to understand which sets of genes may be appropriate for testing and targeting in the context of personalized patient care, attendees heard at the American Society of Clinical Oncology annual meeting here this weekend.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.